INTRODUCTION Psoriasis is a chronic, inflammatory skin condition that affects 3.2% of the US population.1 A significant portion of patients with psoriasis have scalp and nail involvement. It has been…

INTRODUCTION Despite the number of available treatments, not all patients with onychomycosis are cured and recurrence (relapse or re-infection) is not uncommon, with percentages reported in various clinical studies ranging…

INTRODUCTION Actinic keratoses (AK) are part of a disease continuum that can progress from initial keratinocyte dysplasia to invasive squamous cell carcinoma (SCC).1 Ultraviolet light affects the entire sun-exposed area…

INTRODUCTION Psoriasis is a common, chronic immune-mediated inflammatory skin disorder with potential systemic complications. Current epidemiological studies demonstrate a prevalence of 0.45-4.6% worldwide, with both ethnic and genetic factors strongly…

INTRODUCTION Psoriasis is a chronic inflammatory disease that affects an estimated 3% of the population in the United States.1 Psoriasis creates a large economic burden for patients and payers; estimates…

INTRODUCTION Psoriasis is a common chronic inflammatory skin condition that affects 3-4% of the adult United States population. 1 The pathogenesis of psoriasis is multifactorial and thought to be due…

INTRODUCTION Current treatment of skin psoriasis achieves approximately a 70% reduction in the Psoriasis Area Severity Index (PASI) with combination vitamin analogues plus corticosteroids, with up to 80% of patients…

INTRODUCTION The recent approval of ivermectin for the treatment of the inflammatory lesions of rosacea is the latest in a series of indications spanning the past 25 years.1,2 The aim…

INTRODUCTION Chronic plaque psoriasis is an inflammatory skin condition reported to affect approximately 2% of the United States adult population.1,2 Topical steroids are the cornerstone of treatment of psoriasis, and…

INTRODUCTION Methotrexate (MTX) is a commonly used agent in the treatment of moderate to severe chronic plaque psoriasis (CPP). Its effectiveness has been established in the dermatological literature.1-4 Even though…